Home » Seattle Genetics to Submit Lymphoma Drug to FDA
Seattle Genetics to Submit Lymphoma Drug to FDA
A pivotal trial of Seattle Genetics’ experimental cancer-targeting antibody for patients with Hodgkin’s lymphoma found that more than a third of them achieved complete remission of their cancer.
Fox News
Fox News
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May